A phase 1/2 safety and efficacy study of TAK-754 gene therapy: The challenge of achieving durable factor VIII expression in haemophilia A clinical trials - Chapin, John; Ayash-Rashkovsky, Mila; Diogo, Dorothee; Kenniston, Jon; Lopez-Jaime, Francisco-Jose; Maggiore, Caterina; Mingot-Castellano, Maria-Eva; Rajavel, Kavitha; Rauch, Antoine; Susen, Sophie; von Grotthuss, Marcin; Wagoner, Matt; et al. (HAEMOPHILIA, 2025)